Stem cell player moves to Mass.

The adult stem cell therapy developer AlloCure has moved from Salt Lake City all the way to Burlington, MA. Lean and mean with fewer than 10 workers, AlloCure also has a new CEO: Robert Brenner. "If we could develop a cell therapy for acute kidney injury, it would be a revolution," Brenner tells Xconomy. "People have been working on this for their entire professional careers." Story